Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation

Thrombosis and inflammation are hallmarks of ischemic stroke still unamenable to therapeutic interventions. High-molecular-weight kininogen (KNG) is a central constituent of the contact-kinin system which represents an interface between thrombotic and inflammatory circuits and is critically involved...

Full description

Saved in:
Bibliographic Details
Main Authors: Langhauser, Friederike (Author) , Pham, Mirko (Author) , Bendszus, Martin (Author)
Format: Article (Journal)
Language:English
Published: August 30, 2012
In: Blood
Year: 2012, Volume: 120, Issue: 19, Pages: 4082-4092
ISSN:1528-0020
DOI:10.1182/blood-2012-06-440057
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1182/blood-2012-06-440057
Verlag, kostenfrei, Volltext: http://www.bloodjournal.org/content/120/19/4082
Get full text
Author Notes:Friederike Langhauser, Eva Göb, Peter Kraft, Christian Geis, Joachim Schmitt, Marc Brede, Kerstin Göbel, Xavier Helluy, Mirko Pham, Martin Bendszus, Peter Jakob, Guido Stoll, Sven G. Meuth, Bernhard Nieswandt, Keith R. McCrae, and Christoph Kleinschnitz
Description
Summary:Thrombosis and inflammation are hallmarks of ischemic stroke still unamenable to therapeutic interventions. High-molecular-weight kininogen (KNG) is a central constituent of the contact-kinin system which represents an interface between thrombotic and inflammatory circuits and is critically involved in stroke development. Kng−/− mice are protected from thrombosis after artificial vessel wall injury and lack the proinflammatory mediator bradykinin. We investigated the consequences of KNG deficiency in models of ischemic stroke. Kng−/− mice of either sex subjected to transient middle cerebral artery occlusion developed dramatically smaller brain infarctions and less severe neurologic deficits without an increase in infarct-associated hemorrhage. This protective effect was preserved at later stages of infarction as well as in elderly mice. Targeting KNG reduced thrombus formation in ischemic vessels and improved cerebral blood flow, and reconstitution of KNG-deficient mice with human KNG or bradykinin restored clot deposition and infarct susceptibility. Moreover, mice deficient in KNG showed less severe blood-brain barrier damage and edema formation, and the local inflammatory response was reduced compared with controls. Because KNG appears to be instrumental in pathologic thrombus formation and inflammation but dispensable for hemostasis, KNG inhibition may offer a selective and safe strategy for combating stroke and other thromboembolic diseases.
Item Description:Gesehen am 01.10.2018
Physical Description:Online Resource
ISSN:1528-0020
DOI:10.1182/blood-2012-06-440057